Rapid Micro Biosystems (RPID) Income from Continuing Operations (2020 - 2026)

Rapid Micro Biosystems has disclosed Income from Continuing Operations across 7 years of filings, most recently posting -$12.9 million for Q2 2026.

• In Q2 2026, Income from Continuing Operations fell 8.98% year-over-year to -$12.9 million; the TTM figure through Jun 2026 stood at -$51.2 million (down 16.07% YoY), while the FY2025 annual figure was -$47.1 million, changed 0.5% from the prior year.
• Income from Continuing Operations came in at -$12.9 million for Q2 2026 at Rapid Micro Biosystems, up from -$14.3 million in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of -$9.7 million in Q4 2024 to a low of -$16.5 million in Q4 2022.
• Average Income from Continuing Operations over 5 years is -$13.0 million, with a median of -$13.0 million recorded in 2022.
• Year-over-year, Income from Continuing Operations surged 34.61% in 2022 and decreased 29.29% in 2025.
• Over 5 years, Income from Continuing Operations stood at -$16.5 million in 2022, then surged by 32.14% to -$11.2 million in 2023, then grew by 13.48% to -$9.7 million in 2024, then retreated by 29.29% to -$12.5 million in 2025, then decreased by 3.41% to -$12.9 million in 2026.
• Per Business Quant data, the three most recent Income from Continuing Operations figures were -$12.9 million in Q2 2026, -$14.3 million in Q1 2026, and -$12.5 million in Q4 2025.